{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T19:52:52Z","timestamp":1793303572912,"version":"4.5.0"},"reference-count":23,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","license":[{"start":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T00:00:00Z","timestamp":1740096000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,2,21]]},"abstract":"<jats:p>This study aimed to investigate the potential causal relationship between depression and Parkinson\u2019s disease (PD) using Mendelian randomization (MR). Summary statistics for depression and PD were obtained from 2 large-scale genome-wide association studies (GWAS) involving individuals of European ancestry. Independent genetic loci associated with depression and PD were identified as instrumental variables. The inverse variance weighting (IVW) approach was used as the primary method for causal inference, while MR-Egger and weighted median methods served as supplementary analyses to verify the robustness of the results. Heterogeneity tests, multiple validity checks, and leave-one-out sensitivity analyses were conducted to assess the reliability of the findings. The IVW analysis yielded an odds ratio of 1.44 (95% confidence interval: 1.001\u20132.077, <jats:italic toggle=\"yes\">P<\/jats:italic>\u2005=\u2005.048), suggesting a potential causal relationship between depression and PD. No evidence of heterogeneity or horizontal pleiotropy was found, and sensitivity analyses confirmed the reliability of the results. This study applied 2-sample MR analysis to genetic data, revealing a causal link between depression and the development of PD. These findings highlight the importance of early screening and intervention for individuals with depression to reduce the risk of developing PD.<\/jats:p>","DOI":"10.1097\/md.0000000000041658","type":"journal-article","created":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T15:00:45Z","timestamp":1740409245000},"page":"e41658","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":3,"title":["Depression and the risk of Parkinson\u2019s disease: A Mendelian randomization study"],"prefix":"10.1097","volume":"104","author":[{"given":"Yongjian","family":"Du","sequence":"first","affiliation":[{"name":"Department of Neurosurgery, The Fifth People\u2019s Hospital of Jinan, Jinan, Shandong Province, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong","family":"Tang","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, The Fifth People\u2019s Hospital of Jinan, Jinan, Shandong Province, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangcheng","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, The Fifth People\u2019s Hospital of Jinan, Jinan, Shandong Province, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-6767-8963","authenticated-orcid":false,"given":"Dezhi","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, The Fifth People\u2019s Hospital of Jinan, Jinan, Shandong Province, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20250805","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1002\/mds.25945","article-title":"The prevalence of Parkinson's disease: a systematic review and meta-analysis.","volume":"29","author":"Pringsheim","year":"2014","journal-title":"Mov Disord"},{"key":"R2-20250805","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/j.parkreldis.2010.06.014","article-title":"Occurrence of depression and anxiety prior to Parkinson's disease.","volume":"16","author":"Jacob","year":"2010","journal-title":"Parkinsonism Relat Disord"},{"key":"R3-20250805","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1212\/01.wnl.0000247740.47667.03","article-title":"Projected number of people with Parkinson disease in the most populous nations, 2005 through 2030.","volume":"68","author":"Dorsey","year":"2007","journal-title":"Neurology"},{"key":"R4-20250805","doi-asserted-by":"crossref","first-page":"155","DOI":"10.2217\/nmt-2022-0001","article-title":"Prodromal depression and subsequent risk of developing Parkinson's disease: a systematic review with meta-analysis.","volume":"12","author":"Bareeqa","year":"2022","journal-title":"Neurodegener Dis Manag"},{"key":"R5-20250805","doi-asserted-by":"crossref","first-page":"479","DOI":"10.3934\/Neuroscience.2022027","article-title":"Depression and Parkinson's disease: a chicken-egg story.","volume":"9","author":"Chakraborty","year":"2022","journal-title":"AIMS Neurosci"},{"key":"R6-20250805","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1111\/jnu.12303","article-title":"Depression as a risk factor of organic diseases: an international integrative review.","volume":"49","author":"Bica","year":"2017","journal-title":"J Nurs Scholarsh"},{"key":"R7-20250805","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1002\/1531-8257(200007)15:4<669::AID-MDS1011>3.0.CO;2-5","article-title":"Anxiety disorders and depressive disorders preceding Parkinson's disease: a case-control study.","volume":"15","author":"Shiba","year":"2000","journal-title":"Mov Disord"},{"key":"R8-20250805","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1038\/nrneurol.2015.126","article-title":"Parkinson disease: depression-risk factor or early symptom in Parkinson disease?","volume":"11","author":"Leentjens","year":"2015","journal-title":"Nat Rev Neurol"},{"key":"R9-20250805","doi-asserted-by":"crossref","first-page":"S54","DOI":"10.5694\/j.1326-5377.2009.tb02471.x","article-title":"Depression, anxiety and their relationship with chronic diseases: a review of the epidemiology, risk and treatment evidence.","volume":"190","author":"Clarke","year":"2009","journal-title":"Med J Aust"},{"key":"R10-20250805","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s13041-018-0356-9","article-title":"Early life stress, depression and Parkinson's disease: a new approach.","volume":"11","author":"Dall\u00e9","year":"2018","journal-title":"Mol Brain"},{"key":"R11-20250805","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1001\/jama.2017.17219","article-title":"Mendelian randomization.","volume":"318","author":"Emdin","year":"2017","journal-title":"JAMA"},{"key":"R12-20250805","doi-asserted-by":"crossref","first-page":"a040501","DOI":"10.1101\/cshperspect.a040501","article-title":"Mendelian randomization: concepts and scope.","volume":"12","author":"Richmond","year":"2022","journal-title":"Cold Spring Harb Perspect Med"},{"key":"R13-20250805","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1097\/EDE.0000000000000559","article-title":"Sensitivity analyses for robust causal inference from Mendelian randomization analyses with multiple genetic variants.","volume":"28","author":"Burgess","year":"2017","journal-title":"Epidemiology"},{"key":"R14-20250805","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1093\/ije\/dyx028","article-title":"Two-sample Mendelian randomization: avoiding the downsides of a powerful, widely applicable but potentially fallible technique.","volume":"45","author":"Hartwig","year":"2016","journal-title":"Int J Epidemiol"},{"key":"R16-20250805","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1002\/gps.4350","article-title":"The longitudinal impact of depression on disability in Parkinson disease.","volume":"31","author":"Pontone","year":"2016","journal-title":"Int J Geriatr Psychiatry"},{"key":"R17-20250805","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.jad.2010.12.006","article-title":"Increased risk of cancer subsequent to severe depression--a nationwide population-based study.","volume":"131","author":"Chen","year":"2011","journal-title":"J Affect Disord"},{"key":"R18-20250805","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/j.parkreldis.2011.11.007","article-title":"Depression and care-dependency in Parkinson's disease: results from a nationwide study of 1449 outpatients.","volume":"18","author":"Riedel","year":"2012","journal-title":"Parkinsonism Relat Disord"},{"key":"R19-20250805","doi-asserted-by":"crossref","first-page":"e46818","DOI":"10.1371\/journal.pone.0046818","article-title":"Major depressive disorder and stroke risks: a 9-year follow-up population-based, matched cohort study.","volume":"7","author":"Li","year":"2012","journal-title":"PLoS One"},{"key":"R20-20250805","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1016\/S1474-4422(16)30230-7","article-title":"The epidemiology of Parkinson's disease: risk factors and prevention.","volume":"15","author":"Ascherio","year":"2016","journal-title":"Lancet Neurol"},{"key":"R21-20250805","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.pnpbp.2018.05.025","article-title":"Association between depression and the subsequent risk of Parkinson's disease: a meta-analysis.","volume":"86","author":"Wang","year":"2018","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"R22-20250805","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.jad.2021.05.038","article-title":"Association between depression and risk of Parkinson's disease in South Korean adults.","volume":"292","author":"Jeong","year":"2021","journal-title":"J Affect Disord"},{"key":"R23-20250805","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1136\/jnnp.2008.152983","article-title":"Use of antidepressants and the risk of Parkinson's disease: a prospective study.","volume":"80","author":"Alonso","year":"2009","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R24-20250805","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/S0140-6736(23)01429-0","article-title":"Medical, surgical, and physical treatments for Parkinson\u2019s disease.","volume":"403","author":"Foltynie","year":"2024","journal-title":"Lancet"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000041658","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,5]],"date-time":"2025-08-05T17:22:46Z","timestamp":1754414566000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000041658"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,21]]},"references-count":23,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000041658","relation":{},"ISSN":["1536-5964"],"issn-type":[{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,21]]}}}